» Authors » Charlotte Verroken

Charlotte Verroken

Explore the profile of Charlotte Verroken including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 184
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Winter E, Dekkers O, Andreasen C, DAngelo S, Appelman-Dijkstra N, Appenzeller S, et al.
Ann Rheum Dis . 2025 Feb; 84(2):169-187. PMID: 39919892
Background: There is considerable practice variation in labelling, diagnosis and treatment of adults with sterile bone inflammation. We developed a expert consensus recommendations on the disease definition, diagnosis and treatment...
2.
Van den Broeck B, Debacker J, Bauters W, Creytens D, Ferdinande L, Huvenne W, et al.
EJNMMI Res . 2024 Sep; 14(1):82. PMID: 39264376
Background: Patients diagnosed with radioiodine refractory (RAI-R) thyroid carcinoma (TC) have a significantly worse prognosis than patients with radiosensitive TC. These refractory malignancies are often dedifferentiated, hindering the effectiveness of...
3.
Verly E, Lapauw B, Verroken C
J Clin Endocrinol Metab . 2024 Apr; 110(3):e783-e790. PMID: 38605120
Context: Treatment of primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism due to idiopathic hypercalciuria (SHPT-IH) is markedly different. Robust diagnostic tools to differentiate between both entities are however lacking. Objective: Evaluate...
4.
Sterenborg R, Steinbrenner I, Li Y, Bujnis M, Naito T, Marouli E, et al.
Nat Commun . 2024 Jan; 15(1):888. PMID: 38291025
To date only a fraction of the genetic footprint of thyroid function has been clarified. We report a genome-wide association study meta-analysis of thyroid function in up to 271,040 individuals...
5.
Banica T, Verroken C, Reyns T, TSjoen G, Fiers T, Kaufman J, et al.
Eur J Endocrinol . 2023 Jun; 188(6):510-518. PMID: 37288537
Objective: Androgen levels decline from early adulthood and decreases are steeper in men with increasing body mass index. It is, however, unclear to what extent changes in other indices of...
6.
Helleputte S, Calders P, Rodenbach A, Marlier J, Verroken C, De Backer T, et al.
Cardiovasc Diabetol . 2022 Dec; 21(1):277. PMID: 36494687
Background: A substantial proportion of type 1 diabetes (T1D) patients free from known cardiovascular disease (CVD) show premature arterial stiffening, with age, blood pressure, and HbA1c-as gold standard of glycemic...
7.
Coussens M, Lapauw B, Verroken C, Goemaere S, De Wandele I, Malfait F, et al.
J Bone Miner Res . 2022 Oct; 37(12):2456-2465. PMID: 36239015
Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous heritable connective tissue disorder mainly characterized by bone fragility and increased fracture risk. This study investigated bone parameters in adults with...
8.
Laurent M, Goemaere S, Verroken C, Bergmann P, Body J, Bruyere O, et al.
Front Endocrinol (Lausanne) . 2022 Jun; 13:908727. PMID: 35757436
Glucocorticoids are effective immunomodulatory drugs used for many inflammatory disorders as well as in transplant recipients. However, both iatrogenic and endogenous glucocorticoid excess are also associated with several side effects...
9.
Verroken C, Collet S, Lapauw B, TSjoen G
Calcif Tissue Int . 2022 Apr; 110(5):615-623. PMID: 35366693
This review discusses the changes in bone mass, structure, and metabolism that occur upon gender-affirming hormonal treatment (GAHT) in transgender adults and adolescents, as well as their clinical relevance. In...
10.
Banica T, Verroken C, TSjoen G, Goemaere S, Zmierczak H, Fiers T, et al.
J Bone Miner Res . 2022 Mar; 37(5):865-875. PMID: 35279881
Bone metabolism in men is in part determined by sex steroid exposure. This is especially clear during puberty and senescence but it remains to be established whether declines in sex...